This hormone helps regulate appetite, insulin secretion, and gastric emptying after meals
Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
Clinical trials demonstrate that maximal therapeutic effects generally require several months of treatment at the target maintenance dose, which is typically reached through a gradual dose escalation process
A central role for hepatocyte growth factor in adipose tissue angiogenesis
also provides research-led background around Retatrutide receptor pathway interest